Servier Pharmaceuticals

Servier is a global pharmaceutical company headquartered in Suresnes, France. Established in 1954, Servier has grown to become a significant player in the international healthcare sector, with a focus on delivering innovative therapeutic solutions. As an independent organisation, Servier is committed to therapeutic progress to serve patient needs.

The company prioritises research and development, investing heavily in discovering and developing new drugs. Servier's extensive portfolio spans several therapeutic areas, including cardiovascular, immune-inflammatory, neuropsychiatric, cancer, and diabetes care. Servier also produces a range of generic drugs, ensuring accessibility and affordability for patients worldwide.

With a workforce of 22,000 employees, Servier operates in over 150 countries. The company’s dedication to improving patient care through scientific innovation and collaboration with healthcare professionals underscores its mission to advance healthcare outcomes globally. Under the leadership of CEO David K. Lee, Servier continues to uphold its values of commitment and innovation, striving for a healthier future for all.